IMCI Pharmaceuticals
IMCI is Making Medical Cannabis: Safer, Effective, and Patient-Focused
Company Overview
Snapshot
Founded in December 2018 by Alon Hershkovitz and Avi Yakobovich, IMCI Pharmaceuticals operates with 1–10 employees. The company is focused on advancing medical cannabis treatments and holds a patent for its technology. IMCI Pharmaceuticals is currently in the Pre-Funding stage.
Business overview
IMCI Pharmaceuticals is a pharma-grade medical cannabis company dedicated to enhancing patient care through scientific innovation, safety, and precision. The company's core technology is the proprietary NanoVATE™ drug-delivery platform, designed to improve cannabinoid bioavailability for fast, accurate, and long-lasting relief. IMCI Pharmaceuticals offers its iCann product line, which includes iCann Fast, iCann Oral, and iCann LA. The company serves the medical cannabis market, with expansion efforts across Europe, Israel, and the U.S., aiming to provide standardized, effective, and stigma-free cannabis treatments.
Strategic signal
In September 2024, IMCI Pharmaceuticals was featured in an article by nocamels.com highlighting its approach to safer medical cannabis. This signals the company's continued efforts to gain visibility and validate its innovative drug delivery platform within the health tech and life sciences sector, emphasizing its potential to address patient needs for effective and safe cannabis treatments.
Log in to access full profile ›Company Intelligence Q&A
- What is IMCI Pharmaceuticals' primary focus?
- IMCI Pharmaceuticals is a pharma-grade medical cannabis company focused on redefining patient care through science, safety, and precision in medical cannabis treatments.
- What is the NanoVATE™ drug-delivery platform?
- The NanoVATE™ drug-delivery platform is IMCI Pharmaceuticals' proprietary technology designed to enhance cannabinoid bioavailability, enabling fast, accurate, and long-lasting relief for patients.
- When was IMCI Pharmaceuticals founded?
- IMCI Pharmaceuticals was founded in December 2018.
- Who are the founders of IMCI Pharmaceuticals?
- The company was co-founded by Alon Hershkovitz and Avi Yakobovich.
- What products does IMCI Pharmaceuticals offer?
- IMCI Pharmaceuticals offers the iCann product line, which includes iCann Fast, iCann Oral, and iCann LA, all leveraging its NanoVATE™ drug-delivery platform.